MSMauro SchechterMD, PhDVideoHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019PrEP After Sexual Exposures - Mauro Schechter, MD, PhDView Video
VTVivian TamayoMDVideoHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019The Puerto Rican Experience: Discussion - Vivian TamayoView Video
KHMKenneth H. MayerMDVideoHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Challenges with the Implementation of PrEP - Kenneth Mayer, MDView Video
ACAndrea CoxMDVideoHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Hepatitis C Elimination: Is It Possible? - Andrea Cox, MDView Video
IAIván AntúnezMDVideoHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Global Challenges in Hepatitis B Treatment - Ivan Antunez-Gonzalez, MDView Video
PCPedro CahnMD, PhDVideoHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Starting HAART in 2019: When and How - Pedro Cahn, MD, PhDView Video
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Clinical case presentation: A preliminary profile of common co-morbidities and risk practices in a sample of HIV/HCV co-infected patients in Puerto RicoView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019A phase 3b, open-label, pilot study to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in virologically suppressed HIV-1 infected adult subjects harboring the NRTI resistance mutation M184V and/or M184I (GS-USView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Implementation science for HIV prevention using an eHealth program for Spanish-speaking sexual minorities groups in Puerto RicoView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019High prevalence of hepatitis B virus infection among chronic kidney disease patientsView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Time to treatment disfavors patients living with HIV/HCV co-infectionView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Prevalence of alcohol and substance use in a sample of patients living with HIV/HCV co-infection who are in routine clinical care receiving antiretroviral therapyView Abstract
